Fundz

Nate Hardy Joins Arsenal Biosciences, Inc. as Chief Financial Officer

PRIVATESep 16, 2024

Position

Chief Financial Officer

Company

Arsenal Biosciences

Nate Hardy
nhardy@arsenalbio.com
South San FranciscoBiotechnologyHealth CareTherapeutics

Description

Nate Hardy will join Arsenal Biosciences, Inc. as Chief Financial Officer, effective October 7, 2024

Quick answer

Nate Hardy Joins Arsenal Biosciences, Inc. as Chief Financial Officer (September 16, 2024). Arsenal Biosciences is based in South San Francisco, California, United States.

Who is the new Chief Financial Officer at Arsenal Biosciences?
Arsenal Biosciences named Nate Hardy Chief Financial Officer, announced September 16, 2024.
What did Arsenal Biosciences announce on September 16, 2024?
Nate Hardy will join Arsenal Biosciences, Inc. as Chief Financial Officer, effective October 7, 2024
What does Arsenal Biosciences do?
Arsenal Biosciences, Inc. (ArsenalBio), headquartered in South San Francisco, Calif., is a privately held programmable cell therapy company discovering and developing a pipeline of next-generation autologous T cell...
Where is Arsenal Biosciences based?
Arsenal Biosciences is based in South San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
89bio (September 17, 2024), Tivic (September 13, 2024), Prilenia (September 19, 2024) and Alchemab Therapeutics (September 12, 2024) also announced leadership changes within 45 days of Arsenal Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Arsenal Biosciences, and when

A new leader at Arsenal Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Arsenal Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arsenal Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arsenal Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arsenal Biosciences

Location

329 Oyster Point Blvd

South San Francisco, California, United States

About

Arsenal Biosciences, Inc. (ArsenalBio), headquartered in South San Francisco, Calif., is a privately held programmable cell therapy company discovering and developing a pipeline of next-generation autologous T cell therapies to defeat cancer. Our full-stack R&D engine generates multifunctional T cell medicines, enabled by precise and specific CRISPR insertion of large synthetic DNA sequences. ArsenalBio is building the industry’s largest DNA library of therapeutic enhancing integrated circuits, incorporating logic gating for improved tumor targeting and synthetic features enabling multiple pharmaceutical functions. In pioneering a computationally driven approach alongside nonviral clinical manufacturing, we aspire to deliver enhanced efficacy, increased patient safety, reduced stakeholder costs, and expanded market access.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arsenal Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ken
Senior decision-maker at this company
••••••••@••••••••

See Ken's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Arsenal Biosciences's next move

Learn about Strategic plan

Arsenal Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.